Summary:
Multi-center, randomized crossover study to evaluate the treatment of acute migraines with oral Ubrogepant.
Qualified Participants Must:
• Must be between the ages of 18-75
•
Suffer from 2-8 migraines a month
•
Be willing to attend study visits
Qualified Participants May Receive:
- Reimbursement for time and travel
- Physical exam, EKG, and laboratory services at no cost
- Study medication at no cost